CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $7,174,000 | -25.2% | 3,092,133 | -50.0% | 0.02% | +54.5% |
Q4 2017 | $9,586,000 | +44.9% | 6,184,266 | +100.0% | 0.01% | -26.7% |
Q3 2017 | $6,617,000 | -66.7% | 3,092,133 | -29.7% | 0.02% | -67.4% |
Q2 2017 | $19,883,000 | +92.8% | 4,398,875 | +27.9% | 0.05% | +91.7% |
Q1 2017 | $10,315,000 | +6.5% | 3,438,484 | -2.0% | 0.02% | +4.3% |
Q4 2016 | $9,685,000 | -16.0% | 3,508,988 | -4.5% | 0.02% | -17.9% |
Q3 2016 | $11,536,000 | -21.8% | 3,673,622 | +27.7% | 0.03% | -22.2% |
Q2 2016 | $14,755,000 | +22.6% | 2,876,099 | -2.2% | 0.04% | +24.1% |
Q1 2016 | $12,033,000 | -49.7% | 2,942,127 | -0.2% | 0.03% | -46.3% |
Q4 2015 | $23,919,000 | +1.2% | 2,949,342 | +5.3% | 0.05% | +1.9% |
Q3 2015 | $23,639,000 | +36.8% | 2,800,736 | +52.6% | 0.05% | +51.4% |
Q2 2015 | $17,275,000 | +33.2% | 1,835,900 | +31.1% | 0.04% | +34.6% |
Q1 2015 | $12,972,000 | +15.8% | 1,400,834 | +15.7% | 0.03% | +13.0% |
Q4 2014 | $11,198,000 | +35.8% | 1,210,643 | +31.1% | 0.02% | +35.3% |
Q3 2014 | $8,245,000 | – | 923,281 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
CLEAR STREET MARKETS LLC | 600 | $4,000 | 0.00% |